As of 2025-10-17, the Relative Valuation of Exagen Inc (XGN) is (12.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.77 USD, the upside of Exagen Inc based on Relative Valuation is -203.4%.
The range of the Relative Valuation is (10.48) - (13.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.6x - 18.2x | 15.6x |
| Forward P/E multiples | 11.7x - 17.8x | 16.0x |
| Fair Price | (10.48) - (13.72) | (12.18) |
| Upside | -189.1% - -216.6% | -203.4% |
| Date | P/E |
| 2025-10-16 | -15.25 |
| 2025-10-15 | -15.44 |
| 2025-10-14 | -14.95 |
| 2025-10-13 | -14.30 |
| 2025-10-10 | -14.19 |
| 2025-10-09 | -14.36 |
| 2025-10-08 | -14.23 |
| 2025-10-07 | -14.20 |
| 2025-10-06 | -14.12 |
| 2025-10-03 | -14.20 |
| 2025-10-02 | -14.11 |
| 2025-10-01 | -14.23 |
| 2025-09-30 | -14.24 |
| 2025-09-29 | -13.95 |
| 2025-09-26 | -14.11 |
| 2025-09-25 | -13.69 |
| 2025-09-24 | -13.97 |
| 2025-09-23 | -12.85 |
| 2025-09-22 | -12.76 |
| 2025-09-19 | -12.39 |
| 2025-09-18 | -12.50 |
| 2025-09-17 | -11.88 |
| 2025-09-16 | -11.80 |
| 2025-09-15 | -12.06 |
| 2025-09-12 | -12.62 |
| 2025-09-11 | -12.96 |
| 2025-09-10 | -12.48 |
| 2025-09-09 | -12.70 |
| 2025-09-08 | -12.71 |
| 2025-09-05 | -12.53 |
| 2025-09-04 | -12.74 |
| 2025-09-03 | -12.54 |
| 2025-09-02 | -12.45 |
| 2025-08-29 | -12.78 |
| 2025-08-28 | -12.62 |
| 2025-08-27 | -12.37 |
| 2025-08-26 | -12.83 |
| 2025-08-25 | -12.76 |
| 2025-08-22 | -13.09 |
| 2025-08-21 | -12.93 |
| 2025-08-20 | -12.75 |
| 2025-08-19 | -12.50 |
| 2025-08-18 | -12.63 |
| 2025-08-15 | -12.30 |
| 2025-08-14 | -12.11 |
| 2025-08-13 | -12.53 |
| 2025-08-12 | -12.39 |
| 2025-08-11 | -12.15 |
| 2025-08-08 | -11.92 |
| 2025-08-07 | -11.65 |